Oncology Screening and Research Readiness
Making screening, navigation, and research participation easier to understand
Cancer prevention, screening, treatment, survivorship, and research participation can be difficult to navigate. People may face barriers related to cost, transportation, fear, mistrust, unclear information, delayed referrals, or lack of support after diagnosis.
Community Circles create a trusted space where community members, partners, and champions can discuss what makes cancer-related services easier or harder to access. These conversations help partners understand where education is needed, what concerns people have about clinical trials, and what kinds of support make screening and research participation feel more approachable.
What We Explore
What Can Participants Expect?
Oncology Community Circles are not medical appointments or research recruitment sessions. They are structured conversations designed to help people learn, ask questions, and share what would make cancer screening, navigation, and research opportunities easier to understand.
The Circle may include plain-language education, guided discussion, resource mapping, participant reflection, and partner learning. Any public summary should be de-identified and focused on community themes, trusted resources, and action steps.
WHO ARE PART OF US?
Partners and Community Champions can help make oncology education and navigation more accessible by sharing clear information, connecting people to trusted screening resources, supporting research readiness, and helping identify where referral pathways need improvement.
Through Community Circles, CHI and partners can better understand how to communicate about screening, survivorship, and research in ways that are respectful, practical, and grounded in community trust.
Help make cancer screening and research readiness more accessible. Join a future Oncology Circle, share trusted resources, suggest a community location, or partner with CHI to support screening literacy, navigation, survivorship support, and clinical trial readiness